Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 1 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Bio Techne Corporation | TECH | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 63.69 | 05:58:52 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 63.69 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 1 | 1 | - | 51.79 - 89.91 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 08:02:42 | 1 | $ 63.69 | USD |
Bio Techne Corporation Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 10.01B | 157.19M | - | 1.14B | 285.26M | 1.81 | 35.10 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Bio Techne News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TECH Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 64.54 | 64.81 | 61.16 | 62.74 | 1,006,734 | -0.85 | -1.32% |
| 1 Month | 69.08 | 71.27 | 61.16 | 66.62 | 976,303 | -5.39 | -7.80% |
| 3 Months | 72.71 | 78.745 | 61.16 | 69.88 | 1,099,558 | -9.02 | -12.41% |
| 6 Months | 63.32 | 78.745 | 51.79 | 67.71 | 1,154,359 | 0.37 | 0.58% |
| 1 Year | 83.52 | 89.91 | 51.79 | 72.30 | 1,028,540 | -19.83 | -23.74% |
| 3 Years | 108.6325 | 135.9625 | 51.79 | 80.59 | 615,506 | -44.94 | -41.37% |
| 5 Years | 47.9875 | 135.9625 | 38.7925 | 77.82 | 439,777 | 15.70 | 32.72% |
Bio Techne Description
| Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%. |
